About
Global pharmaceutical company. The EyeBio acquisition (Restoret, up to $3bn) is its big ophthalmology entry.
HQ: Rahway, NJ, USA
Funding
Public (NYSE: MRK)
—Company profile
Global pharma — bought EyeBio for up to $3bn to enter ophthalmology.
Global pharmaceutical company. The EyeBio acquisition (Restoret, up to $3bn) is its big ophthalmology entry.
HQ: Rahway, NJ, USA